Literature DB >> 19732979

Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention.

José Luis Ferreiro1, Joan Antoni Gómez-Hospital2, Ángel R Cequier2, Dominick J Angiolillo3, Gerard Roura2, Luis Teruel2, Jaume Maristany2, Josep Gómez-Lara2, Francesc Jara2, Theodore A Bass4, Enric Esplugas2.   

Abstract

We describe a single-center experience in using the Impella Recover LP 2.5 in the setting of high-risk elective percutaneous coronary interventions. This device is placed percutaneously to support cardiac output and has a better profile than other left ventricular assist devices. Our study shows that the use of the Impella Recover LP 2.5 device is feasible, has an overall favorable safety profile, and may help prevent periprocedural and short-term complications derived from high-risk procedures. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 19732979     DOI: 10.1016/j.ijcard.2009.08.003

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Percutaneous ventricular assist devices: new deus ex machina?

Authors:  Diego Arroyo; Stéphane Cook
Journal:  Minim Invasive Surg       Date:  2011-07-31

2.  Percutaneous cardiac support during myocardial infarction drastically reduces mortality: perspectives from a swine model.

Authors:  Maria Giovanna Trivella; Alessandra Piersigilli; Fabio Bernini; Gualtiero Pelosi; Silvia Burchielli; Stefano Puzzuoli; Claudia Kusmic; Antonio L'Abbate
Journal:  Int J Artif Organs       Date:  2017-06-06       Impact factor: 1.595

3.  Unprotected versus protected high-risk percutaneous coronary intervention with the Impella 2.5 in patients with multivessel disease and severely reduced left ventricular function.

Authors:  Tobias Becher; Frederik Eder; Stefan Baumann; Dirk Loßnitzer; Berit Pollmann; Michael Behnes; Martin Borggrefe; Ibrahim Akin
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

4.  Manual compression versus MANTA device for access management after impella removal on the ICU.

Authors:  Florim Cuculi; Philipp Burkart; Giacomo Cioffi; Federico Moccetti; Mehdi Madanchi; Thomas Seiler; Stefanie Hess; Mathias Wolfrum; Magiliny Jeyarasa; Sonja Meier; Silvia Kuzmiakova; Maani Hakimi; Robert Seelos; Richard Kobza; Stefan Toggweiler; Adrian Attinger-Toller; Matthias Bossard
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.